2019 IPO

Harpoon Therapeutics Stock

Harpoon Therapeutics is a preclinical stage biotechnology company.

Sign up today and learn more about Harpoon Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Harpoon Therapeutics Stock

Harpoon Therapeutics is a preclinical stage biotechnology company founded by MPM that is developing a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets.

Funding History

April 2016$15.0M
May 2017$45.0M
November 2018$70.0M

Management

Vice President

Che-Leung Law

CFO

William E. Picht

Co-Founder

Luke Evnin

President & CEO

Gerald McMahon

SENIOR VICE PRESIDENT

Holger Wesche

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo